Login to Your Account



Sofinnova Closes $312M 7th Fund; Bets on Life Sciences

By Cormac Sheridan
Staff Writer

Wednesday, December 12, 2012
Europe's cash-starved biotechnology sector has another €240 million (US$312 million) to aim for, following Sofinnova Partners' successful closing of its seventh fund.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription